The BMJ, December 17. 2015. Dr. Diana Zuckerman from The National Center for Health Research shared, “There’s a world of difference between talking about approval standards in general and crafting specific legislative language. It is outrageous that FDA officials and regulated industry are sitting down to craft legislative language to give to congressional staff.”
A controversial proposed new health law would have had a terrible impact on the lives of Alzheimer’s patients, who would have been more likely to develop skin cancer and at the same time had no benefit to their memory.
Washington Post, June 17, 2015. A new study published Tuesday in the Journal of Clinical Endocrinology and Metabolism found a startling link between pregnant women exposed to DDT and the breast cancer risk to their daughters.
By Diana Zuckerman, PhD, Nyedra Booker, PharmD, MPH, and Sonia Nagda, MD, MPH Reproductive Health Matters, December 2012 Tens of thousands of defective silicone breast implants were recalled in Europe in 2011–12 soon after the FDA’s unrelated announcement that a rare cancer of the immune system was associated with all saline and silicone gel breast […]
2006 Report by the National Research Center for Women & Families
Archives of Surgery, July 2006